According to polling data from the American Dental Association Health Policy Institute, 99% of dental practices are open and treating patients, which is great news. However, one-third reported difficulty in recruiting dentists, dental…

J. Tim Wright, DDS, MS, Distinguished Bawden Professor in the Department of Pediatric Dentistry at the University of North Carolina at Chapel Hill (UNC-CH) Adams School of Dentistry, will serve as the 14th editor in chief of the Journal…

Sebastian G. Ciancio, DDS, a distinguished service professor in the Department of Periodontics and Endodontics and director of the Center for Dental Studies in the Schools of Medicine and Dentistry, State University of New York at Buffalo…

DentaQuest, the nation’s leading purpose-driven oral health organization, has announced its 2020 Health Equity Heroes – Heroes in the Time of COVID-19.

A recreational hockey game played in June in Tampa Bay, Florida, led to 14 players and one ice rink staff member becoming ill, with 13 of those testing positive for COVID-19. The United States Centers for Disease Control and Prevention…

The World Health Organization released preliminary results on the effectiveness of four COVID-19 treatments, and they were lackluster at best. The 11,000-person trial focused on the use of Remdesivir, Hydroxychloroquine, Lopinavir…

Researchers from the Graduate School of Tokyo Dental College, Ziauddin University, Hayatabad Medical Complex, and King Saud University attempted to regenerate a biocompatible osteodentin-like, hard-tissue matrix in order to replace…

Imagine using LEGO-like scaffolding to rebuild jawbones prior to placing dental implants. This new method of healing and repairing hard tissue is detailed in the study, “3D Printing of Microgel‐Loaded Modular Microcages as Instructive…

Researchers at the University of Minnesota School of Public Health in Minneapolis suggest patients with periodontal disease are at higher risk for cognitive impairment and dementia than the general population. The study, “Periodontal…

Pfizer CEO Albert Bourla, DVM, PhD, posted a letter on the company’s website noting that the Pfizer/BioNTech COVID-19 vaccine should be ready to apply for the United States Food and Drug Administration’s (FDA) Emergency Use Authorization…